Oukang Pharmaceutical announced that the company received the CEP certificate for the diosmin API issued by the European Medicines Quality Administration, covering micronized and non-micronized products in the pyridine synthesis process. The certificate number is CEP 2026-373-Rev 00, and the effective date is September 24, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.